Grieu et al. [62] have also reported that MMP-2 TT homozygous patients had smaller breast tumours (p = 0.006) and contained lower concentrations of the estrogen receptor (ER; p = 0.002) compared to patients with the MMP-2 CC or CT genotype. This evidence concerns the gene MMP2 and breast neoplasm.